CANNAPHARMARX, INC. Net Income (Loss) Attributable to Parent, Diluted
CANNAPHARMARX, INC. (CPMD) reported Net Income (Loss) Attributable to Parent, Diluted of -$1.67 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-16.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToParentDiluted · last filed 2021-08-16
- CANNAPHARMARX, INC. net income (loss) attributable to parent, diluted for the quarter ending 2021-06-30 was -$1.67M.
- CANNAPHARMARX, INC. net income (loss) attributable to parent, diluted for the quarter ending 2021-03-31 was $1.20M.
- CANNAPHARMARX, INC. net income (loss) attributable to parent, diluted for the quarter ending 2020-09-30 was -$2.65M.
- CANNAPHARMARX, INC. net income (loss) attributable to parent, diluted for the quarter ending 2020-06-30 was -$1.47M.
- CANNAPHARMARX, INC. net income (loss) attributable to parent, diluted for fiscal 2020 was -$19.89M.
- CANNAPHARMARX, INC. net income (loss) attributable to parent, diluted for fiscal 2019 was -$20.45M.
| Period end | Net Income (Loss) Attributable to Parent, Diluted 3 month | Net Income (Loss) Attributable to Parent, Diluted 6 month | Net Income (Loss) Attributable to Parent, Diluted 9 month | Net Income (Loss) Attributable to Parent, Diluted 12 month |
|---|---|---|---|---|
| 2021-06-30 | -$1.67M 10-Q · filed 2021-08-16 | -$467.44K derived: sum of 2 quarters · filed 2021-08-16 | ||
| 2021-03-31 | $1.20M 10-Q · filed 2021-08-16 | |||
| 2020-12-31 | -$19.89M 10-K · filed 2021-04-14 | |||
| 2020-09-30 | -$2.65M 10-Q · filed 2020-11-12 | -$4.13M derived: sum of 2 quarters · filed 2021-08-16 | -$8.34M derived: sum of 3 quarters · filed 2021-08-16 | |
| 2020-06-30 | -$1.47M 10-Q · filed 2021-08-16 | -$5.69M derived: sum of 2 quarters · filed 2021-08-16 | ||
| 2020-03-31 | -$4.21M 10-Q · filed 2021-08-16 | |||
| 2019-12-31 | -$20.45M 10-K · filed 2021-04-14 | |||
| 2019-09-30 | -$9.32M 10-Q · filed 2020-11-12 | -$10.07M derived: sum of 2 quarters · filed 2020-11-12 | -$11.21M derived: sum of 3 quarters · filed 2020-11-12 | |
| 2019-06-30 | -$748.08K 10-Q · filed 2020-11-12 | -$1.89M derived: sum of 2 quarters · filed 2020-11-12 | ||
| 2019-03-31 | -$1.14M 10-Q · filed 2020-11-12 |